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A novel immunoassay is reported which uses an enzyme- 
coding DNAhgment as label (expression immunoassay). 
The DNA label is determined with high sensitivity by 
measuring the enzymatic activity produced after expres- 
sion. A DNA fragment encoding the firefly luciferase is 
biotinylated and complexed with streptavidin. Biotinyl- 
ated, specific antibodies are used for quantitation of 
antigen immobilized on microtiter wells. After completion 
of the immunoreaction, streptavidin-DNA is bound to the 
immunocomplex. Subsequent expression of the solid 
phase-bound DNA, by an one-step (coupled) cell-free 
transcription/translation, produces luciferase. The en- 
zyme catalyzes the luminescent reaction of luciferin with 
02 and ATP. As few as 3000 molecules of DNA label can 
be detected. Also, 50000 antigen molecules can be 
detected, and the luminescence is a linear function of the 
number of antigen molecules in a range extending over 3 
orders of magnitude. The high sensitivity achieved is a 
result of the combined amplification due to transcription/ 
translation and the substrate turnover. 
Immunoassay is a powerful analytical technique used widely 
both in the investigation of the fine structure and function of 
biological systems and in the clinical laboratory for diagnosis and 
monitoring of various diseases.’ In recent years, significant 
advances have emerged in immunoassay reagents (antibodies) 
and detection systems. Progress in antibody engineering has 
allowed the production of antibodies endowed with novel proper- 
ties, such as bispecific and catalytic an t ibod ie~ .~ ,~  In parallel, 
considerable efforts have been focused on the improvement of 
immunoassay sen~itivity.’>~-~ Highly sensitive immunoassays are 
expected to provide valuable information on antigens found at 
levels that are close or below the current assay detection limit 
(e.g., antigens involved in early steps of signal transduction 
pathways), allow the monitoring of tumor-specific products in 
blood (for early detection of relapse), and facilitate the search for 
new diagnostic markers of disease. Sensitivity is determined 
mainly by the detectability of the molecules used for antibody 
labeling. Radioactive labels dominated in the immunoassay field 
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for at least 2 decades. However, the current trend is toward novel 
nonisotopic systems with superior sensitivities. Nonisotopic 
immunoassays based on fluorescent, chemiluminescent, or en- 
zyme labels have been developed and are commercially 
a~ailable.’>~-~ Enzymes are probably the most widely used 
nonisotopic labels because they provide amplification through the 
high turnover of substrate to detectable products. The replace- 
ment of conventional chromogenic substrates with new ones that 
allow monitoring of enzymatic activity by fluorescence or chemi- 
luminescence has further improved the 
Cell-free transcription and translation have been used exten- 
sively in the study of the factors involved in the regulation of gene 
expression? In this report, the combined transcription/translation 
process is realized as a highly sensitive analytical system. Indeed, 
transcription entails synthesis of several mRNA molecules from 
each DNA template. Translation, in turn, produces more than 
one protein molecule from each transcript. If the DNA template 
encodes an enzymatically active protein, then ampliication is 
further enhanced due to substrate turnover. 
In expression immunoassay, the label is a DNA fragment that 
encodes an enzyme. The firefly luciferase-coding DNA is chosen 
as a model. The immunoreaction is carried out with biotinylated 
antibodies which, after the immunoreaction is completed, are 
attached to the DNA using streptavidin as a “bridge” molecule. 
The DNA is then subjected to coupled cell-free transcription/ 
translation, which generates several luciferase molecules. Lu- 
ciferase catalyzes the reaction of luciferin, ATP, and 02 to produce 
oxyluciferin, AMP, pyrophosphate, COZ, and light:JO The lumi- 
nescence is proportional to the number of antigen molecules 
present. 
EXPERIMENTAL SECTION 
Instrumentation. Luminescence measurements were carried 
out using a liquid scintillation counter (Model LS6500, Beckman 
Instruments Inc., Fullerton, CA) in the single-photon monitoring 
mode. An imaging densitometer (Model GS670, Bio-Rad Labo- 
ratories Ltd., Mississauga, Canada), along with the Molecular 
Analyst version 1.0 software, was used for quantitation of DNA 
fragments after agarose gel electrophoresis. The miniature 
horizontal gel system MLB-06 from Tyler Research Corp. (Ed- 
monton, Canada) was used for electrophoresis. Time-resolved 
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fluorescence was measured with the CFI 615 Immunoanalyzer 
from CyberFluor Division, Nordion International (l'oronto, Canada). 
Excitation and emission wavelengths were set at 337 and 615 nm, 
respectively. High-performance liquid chromatography (HPLC) 
was performed using the Shimadzu system (Shimadzu Corp., 
Kyoto, Japan) with absorbance monitoring. The G24 environ- 
mental incubator shaker from New Brunswick Scientific (Edison, 
NJ) was employed for culturing bacteria. 
Materials. For preparation of the DNA template, we used a 
plasmid contained, as a control DNA, in the TNT "7 wheat germ 
extract, a transcription/translation system commercially available 
from Promega Corp. (Madison, W. The Wizard maxipreps DNA 
purification system and beetle luciferin were also from Promega. 
The restriction enzymes Alw44 I and PvuII, as well as the 
Geneclean DNA purification system, were purchased from BioCan 
Scientific (Mississauga, Canada). Ultrapure 2'-deoxyribonucleo- 
side 5'-triphosphates, the Klenow fragment of the Escherichia coli 
DNA polymerase I, and coenzyme A (CoA) were from Pharmacia 
Biotech (Montreal, Canada). Linear DNA markers (A-DNA 
digested with EcoRI and Hind10 containing fragments from 0.12 
to 21.2 kbp, supercoiled DNA markers (sizes 2.07-16.2 kbp), 
streptavidin, magnesium carbonate pentahydrate, and tricine were 
from Sigma (St. Louis, MO). Firefly luciferase (from Photinus 
p y a l k ) ,  alkaline phosphatase-labeled streptavidin, adenosine tri- 
phosphate (ATP), bovine serum albumin, and the "blocking 
reagent" (Catalog No. 1096 176) were obtained from Boehringer 
(Laval, Canada). Biotin-14dCTP (biotin attached at the N4 position 
of cytidine by a 14atom linker) and "U-bottom polystyrene 
microtiter wells (Nunc, Maxisorp) were obtained from Life 
Technologies (Burlington, Canada). White, flat-bottom polysty- 
rene wells, Microlite 2, were from Dynatech Laboratories Inc. 
(Chantilly, VA). Monoclonal anti-thyrotropin antibody was from 
Medix Biochemica (Finland). Biotinylated goat anti-mouse anti- 
body was from Jackson Immunoresearch Laboratories, Inc. 
(distributed by BioCan). The phosphate ester of fluorosalicylic 
acid (FSAP) was from CyberFluor. Microcon-30 microconcen- 
trators were purchased from Amicon Inc. (Beverly, MA). 
The blocking solution contained 1% blocking reagent in 0.1 
mol/L maleate and 0.15 mol/L NaCl, pH 7.5. The wash solution 
consisted of 50 mmol/L Tris, pH 7.4, 0.15 mol/L NaCl, and 0.1% 
(v/v) Tween-20. The phosphate-buffered saline (PBS) contained 
10 mmol/L sodium phosphate, 1.8 mmol/L potassium phosphate, 
0.14 mol/L NaCl, and 2.7 mmol/L KCl, pH 7.4. The Tris-EDTA 
(TE) buffer consisted of 10 mmol/L Tris and 1 mmol/L EDTA, 
pH 8.0. A wheat germ-based transcription/translation mixture 
(wheat germ TNT system from Promega) was prepared according 
to the manufacturer's instructions. The complete mixture con- 
sisted of wheat germ extract (containing ribosomes, tRNA, and 
other translation factors), "7 RNA polymerase, and amino acids 
in the appropriate buffer. 
Preparation and Purification of the DNA Template. For 
growing E. coli JM 109 cells, preparation of competent cells, and 
transformation with the plasmid DNA, we followed standard 
procedures.6 Transformed bacteria were grown overnight in LB 
broth (10 g/L tryptone, 5 g/L yeast extract, 0.17 mol/L NaCl, 
and 2 mmol/L NaOW containing 0.1 g/L ampicillin. The plasmid 
DNA was purified from a 1 L bacterial culture with the Wizard 
maxipreps DNA purification system according to the manufac- 
turer's instructions. The size of the plasmid was confirmed by 
agarose (0.7%) gel electrophoresis and ethidium bromide staining, 
using the supercoiled DNA markers. The plasmid concentration 
was determined from the absorbance at 260 nm. For preparation 
of the DNA template, 40 pg of plasmid DNA was first digested 
for 90 min at 37 "C with 240 units ofAlw441 in 150 pL of digestion 
buffer (10 mM Tris-HC1, pH 7.9, 50 mM NaCl, 10 mM MgClz, 
and 1 mM dithiothreitol). Subsequently, a fill-in reaction was 
initiated by adding 150 pL of a solution containing 80 pmol/L of 
each of dATP, dGTP, d'lTP, and biotin-14dCTP as well as 40 units 
of the Klenow fragment of the DNA polymerase I. After incuba- 
tion for 10 min at room temperature, the reaction was terminated 
by heating the mixture at 70 "C for 5 min. Subsequently, 240 
units of PvuII was added, followed by a 90 min incubation at 37 
"C. After digestion, the DNA fragments were separated by 
agarose gel (0.7%) electrophoresis and stained with ethidium 
bromide. The band corresponding to 2.1 kbp was excised, and 
the DNA was purified using the Geneclean purification system 
and recovered in water. To quantitate the purified DNA template, 
we performed another electrophoresis and staining, as above. A 
lane containing the linear DNA markers was also included for 
construction of a calibration curve. The gel was photographed 
under W excitation using a Polaroid 665 film, and the negatives 
were scanned by the densitometer. 
Preparation and Purification of Streptavidm-DNA Tem 
plate Complex. The streptavidin-DNA template complex was 
prepared in a final volume of 80 pL containing 3.6 pg (2.6 pmol) 
of (biotinylated) DNA template and 5 pg (84 pmol) of streptavidin 
in TE buffer. After incubating for 30 min at room temperature, 
the complex (50 pL) was purified by HPLC using a size exclusion 
column (the Bio-Si1 Sec 400-5, 300 mm x 7.8 mm from Bio-Rad 
Laboratories) isocratically. The mobile phase was 50 mM NaHz- 
P01,50 mM Na2HP04, and 150 mM NaCl, pH 6.8. The flow rate 
was 0.5 mWmin. Absorbance was monitored at 260 nm. A 1 mL 
fraction, corresponding to the void volume peak, was collected. 
Next, 100 pL of blocking solution was added (as a carrier), and 
the mixture was concentrated down to about 60 pL by using 
Microcon-30 microconcentrators. A 3 pL aliquot of this prepara- 
tion was electrophoresed, and the DNA concentration was 
determined by scanning densitometry as above (see Preparation 
and Purification of the DNA Template). 
Luciferase Assay. The substrate solution for luciferase 
contained 20 mmol/L tricine, 1.1 mmol/L magnesium carbonate 
pentahydrate, 2.7 mmol/L MgS04,O.l mmol/L EDTA, 33 mmol/L 
dithiothreitol, 270 pmol/L CoA, 530 pmol/L ATP, and 470 pmol/L 
luciferin, pH 7.8." For the luciferase assay, 10 pL of the sample 
was added to 50pL of substrate solution in a microcentrifuge tube. 
The tube was placed in a glass scintillation vial, and the 
luminescence was measured for 1 min using the liquid scintillation 
counter in the single-photon monitoring mode. 
Quantitation of Immobilized Antigen by Expression Im- 
munoassay. Solutions with various analyte concentrations were 
prepared by diluting a monoclonal anti-thyrotropin antibody in 
coating buffer (0.1 mol/L carbonate buffer, pH 9.6). The analyte 
was immobilized by pipetting 25 pL of solution into " U  bottom 
polystyrene microtiter wells and incubating overnight at 4 "C. The 
wells were then washed once with wash solution, and the 
remaining binding sites were blocked for 90 min at room 
temperature with blocking solution. Afterward, the wells were 
washed once as above, and to each well was added 25 pL of 5 
(11) Titus, D. E. Promega Protocols and Applications Guide, 2nd ed.: Promega 
Corp.: 1991. 
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Figure 1. Principle of expression immunoassay. Antigen im- 
mobilized in microtiter wells is allowed to react with a biotinylated 
specific antibody. The immunocomplex is then reacted with strepta- 
vidin-DNA template. The solid phase-bound DNA is subjected to a 
coupled (one-step) transcription1 translation that produces enzyme 
molecules, which are subsequently detected by adding the appropri- 
ate substrate. 
pg/mL biotinylated goat anti-mouse antibody, diluted in blocking 
solution. The immunoreaction was allowed to proceed for 30 min, 
and the wells were washed four times to remove the excess 
biotinylated antibody. Next, 25pL/well ofthe streptavidin-DNA 
template complex (0.65 pg/mL with respect to DNA), diluted in 
blocking solution, was added. The wells were incubated for 10 
min to allow for binding of the complex to biotinylated antibody, 
and the excess complex was removed by washing five times with 
wash solution and three times with TE buffer. Subsequently, 25 
pL of the transcription/translation mixture was added into each 
well and incubated at 30 "C for 90 min, to allow expression of the 
DNA template bound to the immunocomplexes. At the end of 
this period, the synthesized luciferase was measured by adding 
10 pL of tbe reaction mixture to 50 pL of substrate solution (as 
above). 
Enzyme-Amplified, Time-Resolved Fluorescence Immu- 
noassay of Immobilized Antigen. The reactions involved in 
enzymeamplified. timeresolved fluorescence immunoassay. up 
to the addition of biotinylated antibody, were as described above 
(see Quantitation of Immobilized Antigen by Expression Immu- 
noassay). Next, 25 pL of a solution containing 400 units/L 
streptavidin-alkaline phosphatase, 6% bovine serum albumin, 50 
mmol/LTris, and 0.5 g/L NaN?, pH 8.0 were added and incubated 
for 15 min. The wells were washed four times with wash solution, 
and 25 uWwell of substrate solution (1 mmol/L fluorosalicyl 
phosphate, 0.1 mol/LTris-HCl. 0.1 mol/LNaCI, 1 mmol/LMgClz, 
pH 9.1) was added. After a 30 min incubation at room tempera- 
ture, the solution was transferred into white, flat-bottom microtiter 
wells, and 75 uL/well of a 0.4 mol/L NaOH. 2 mmol/L 'E'+. 3
mmol/L EDTA and 1 mol/L Tris, pH 12.5, solution was added. 
The wells were shaken for 1 min, and the fluorescence was 
measured with a timeresolved fluorometer. 
RESULTS AND DISCUSSION 
The principle of expression immunoassay is presented in 
Figure 1. The DNA template that was used as label was a linear 
DNA fragment prepared from a suitable plasmid (4.3 kbp) 
containing the luciferasecoding sequence downstream of a T7 
RNA polymerase promoter (Figure 2a). The plasmid was first 
digested with Alw441, a reaction that produced three fragments. 
The recessed 3' ends created by Ah441  were filled-in with the 
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Klenow fragment of DNA polymerase I in the presence of dATP, 
dGTF', dlTP, and biotin-dCTP. At the end of this step, both 
termini of each DNA fragment were biotinylated. Subsequent 
digestion with PuuII removed a 0.49 kbp part from the biggest 
fragment, just upstream from the T7 promoter, thus leaving a 2.1 
kbp fragment labeled with biotin only at the one terminus (Figure 
2b,c). The fragments were separated by agarose gel electre 
phoresis and stained with ethidium bromide. The 2.1 kbp band 
was excised, and the DNA was purified and used as a label (DNA 
template). The concentration of the DNA template was deter- 
mined by scanning densitometry. 
To test if the DNA template was biotinylated. we mixed 0.5 
pg  of the template with a 3@fold molar excess of streptavidin 
(diluted in TE buffer) and incubated the mixture for 30 min. 
Solutions of the DNA with and without streptavidin were then 
electrophoresed and stained. In the presence of streptavidin. the 
DNA mobility decreased, due to the formation of streptavidin- 
biotin-DNA complexes. In parallel, a non-biotinylated DNA 
template was prepared exactly as above but using dCTP instead 
of biotin-dCTP. I h e  electrophoretic mobility of this fragment 
was (as expected) not affected by the presence of streptavidin. 
Biotinylated and non-biotinylated DNA templates showed identical 
mobilities in the absence of streptavidin. 
To assess the pelformance of transcription/translation as an 
analytical system, various amounts of DNA template were sub- 
jected to a coupled transcription/translation reaction for 90 min 
at 30 "C, in a total volume of 25 pL. After completion of the 
reaction, 10 1 L  aliquots of the mixtures were added to 50 pL of 
luciferase substrate solution, and the luminescence was measured 
for 1 min. Figure 3 shows that the luminescence is linearly related 
to the number of DNA template molecules in the range of 3 x 
1Ct-8 x 106. The curvature observed at higher numbers of 
molecules is due to saturation of the liquid scintillation counter 
from the light produced. From the signals obtained at various 
DNA levels and a luciferase calibration curve, prepared by diluting 
commercially available purified luciferase in the transcription/ 
translation reaction mixture, it was estimated that 12-14 mol- 
ecules of luciferase are synthesized from each DNA template 
molecule. 
The time dependence of luciferase synthesis from immobilized 
DNA template was studied by binding the biotinylated template 
on streptavidin-coated wells, followed by coupled transcription/ 
translation. Wells were coated overnight with 25 pL of 1.4 pg/ 
mL streptavidin in PBS and then washed three times with wash 
solution and blocked for 30 min with blocking solution. DNA 
template (25/cL), also diluted in blocking solution, was incubated 
for 30 min with the solid phase, and the wells were washed three 
times as above and once with TE buffer. Next 25 pL of 
transcription/translation mixture was added. During incubation 
at 30 "C, 1 pL aliquots were removed, and the luciferase was 
measured. The results Figure 4) show that luciferase synthesis 
reaches a plateau after 90 min. The plateau has also been 
observed in liquid phase transcription/translationl" (DNA template 
in solution) and is probably due to inactivation of translation factors 
with prolonged incubation. 
The DNA template was attached to biotinylated antibodies by 
using streptavidin as a linker. We first prepared a 1:l complex of 
the biotinylated DNA with streptavidin by reacting the template 
with a 30fold molar excess of streptavidin. The complex was 
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Figure 2. (a) Plasmid containing the T7 promoter and the luciferase-coding sequence (luc). (b) Structure of the DNA template. A single biotin 
molecule has been added downstream of the luciferase-coding sequence. (c) Analysis of the digested plasmid by 0.7% agarose gel electrophoresis 
and ethidium bromide staining. Lane 1. linear DNA markers (1.4 pg); lane 2, plasmid (1 pg) digested with AIM41 (fragment sizes: 2.59. 1.25. 
and 0.50 kbp); lane 3, plasmid (1 pg) after filling-in reaction and digestion with PvU(1 (fragment sizes: 2.10. 1.25, and 0.50 kbp). 
DNA template molecules 
Figure 3. Quantitation of the luciferase-coding DNA template (label) 
by coupled transcriptionltranslation. 
separated from free streptavidin by sizeexclusion HPLC. The 
streptavidin-DNA template complex was eluted at the void 
volume (9.5 min). whereas free streptavidin came off at 20.3 min. 
To assess the performance of expression immunoassay, we 
immobilized various amounts of antigen (an anti-thyrotropin 
monoclonal antibody) on microtiter wells and used a biotinylated 
goat anti-mouse antibody for detection. After completion of the 
immunoreaction, the streptavidin-DNA was bound to the immu- 
nocomplexes; the excess reagent was washed out and the 
transcription/translation mixture added directly to the solid phase. 
During the 90 min incubation period, DNA template molecules 
bound to the immunocomplexes were expressed, and luciferase 
was synthesized. Aliquots of the reaction mixtures were then 
mixed with substrate solution, and the luminescence was meas 
ured. The results are presented in Figure 5. There is a linear 
0 1 2 3 4 5 
Time (hours) 
Figure 4. Time dependence of the expression of immobilized DNA 
template. Streptavidin-coated microtiter wells were incubated for 30 
min with 25pL of (1) 4.6 and (2) 0.9 nglmL biotinylated DNA template 
solution. After washing, the immobilized template was expressed and 
luciferase activity monitored. 
relationship between luminescence and the amount of antigen 
present in the well, in the range of 5 x 104-1 x loR molecules. 
After antigen immobilization and blocking, the time required for 
detection was about 130 min. The  CV obtained at the level of 106 
molecules was 7.5%. 
Expression immunoassay was compared directly with enzyme 
amplified, timeresolved fluorometric immunoassay, one of the 
most sensitive immunoassay systems currently available.lJ--ll In 
(13) Chrirtopoulos. T. K: Diamandis, E. P. Anal. Chem. 1992. 64. 342-346. 
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197,213-224. 
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1157A. 
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Figure 5. Quantitation of antigen immobilized on microtiter wells 
by expression immunoassay (1) and enzyme-amplified, time-resolved 
fluorescence immunoassay (2). The assays were performed as 
described in the Experimental Section. The luminescence and the 
time-resolved fluorescence measured were plotted against the 
number of molecules of antigen in the well. 
this assay, after completion of the immunoreaction, alkaline 
phosphatase-labeled streptavidin was added into the wells. Sub- 
sequent hydrolysis of the substrate (FSAP) produced fluoro- 
salicylate, which forms fluorescent complexes with Tb3+-EDTA. 
The fluorescence was linearly related to the number of antigen 
molecules in the range of 5 x 106-1 x l o 9  (Figure 5 ) .  
For expression immunoassay to be feasible and highly sensi- 
tive, the following characteristics are desirable: (a) Posttransla- 
tional modification of the synthesized protein is not required for 
full enzymatic activity. This is because the current in vitro 
transcription/translation systems do not allow for specific modi- 
fications after expression. @) The enzyme can be monitored 
directly and conveniently in the transcription/translation mixture. 
(c) Preferably, the enzyme should either consist of a single 
polypeptide chain or be an oligomer of identical subunits. In the 
case of oligomeric enzymes, however, the number of fully active 
enzyme molecules synthesized from each DNA template de- 
creases as the number of subunits increases. (d) Short DNA 
templates (encoding low molecular weight enzymes), in principle, 
should give higher transcription/translation yields than longer 
ones and thus higher sensitivities. Luciferase was chosen as a 
model in this work because it combines the above characteristics. 
It is a single polypeptide chain (550 amino acids) and requires 
no posttranslational modification, and the luciferase cDNA has 
been used as a reporter gene in biological studies, where the 
enzymatic activity was measured conveniently in various tissue 
ex t rac t~ .~J~J6  
The use of coupled transcription/translation in the present 
work greatly enhances the practicality of the proposed system 
by eliminating the need for purification of the mRNA transcripts 
before translation. 
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Previous attempts at direct chemical conjugation of luciferase 
to antibodies have shown that the enzyme is inactivated during 
coupling reactions! Progress in DNA technology has allowed 
the preparation of recombinant fusion proteins in which the 
enzyme is “genetically” conjugated to protein A,’? a protein that 
binds to the Fc portion of immunoglobulin G. Although this 
approach gives better conjugates than chemical coupling, there 
is only one enzyme molecule attached per antibody. In contrast, 
by using an enzyme-coding DNA fragment as label, instead of 
the enzyme itself, problems of inactivation due to coupling are 
avoided, a significant amplification is achieved, and the generated 
enzyme molecules are free in the solution. 
DNAs are generally more stable than proteins (enzymes). 
Nucleases (ii present in the sample) are not expected to affect a 
noncompetitive immunoassay. The reason is that after antigen 
immobilization (or capture), the solid phase is washed several 
times. Similarly, a washing step follows the addition of biotinylated 
detection antibody. Therefore, all the sample constituents that 
could degrade the DNA label or interfere with the transcription/ 
translation reactions are efficiently removed. 
Recently a highly sensitive detection system, termed immuno- 
PCR (polymerase chain reaction), has been reported.’* Although 
both systems use DNA as a label, the underlying concepts are 
quite different. Immuno-PCR replicates the label, thus generating 
a large number of copies which are then detected by electro- 
phoresis. On the other hand, the system proposed here expresses 
the label into a protein with catalytic activity. As a consequence, 
the requirements for the labels differ considerably. Any DNA 
fragment can be used as a label for immuno-PCR along with 
suitable primers. The DNA label in expression immunoassay, 
however, is designed to contain sequences that enable it to 
function as a template for subsequent transcription and translation. 
We have demonstrated the principle of expression immuno- 
assay with a DNA template prepared from a commercially available 
vector without optimizing its structure. The sensitivity could be 
further enhanced by incorporating appropriate promoter, en- 
hancer, or termination sequences in the DNA template that ensure 
the highest yield of the transcription/ translation In 
principle, expression should produce hundreds of enzyme mol- 
ecules per DNA template. These possibilities are currently being 
investigated in our laboratory. 
In conclusion, the contribution of the present work lies in the 
fact that it introduces (for the first time) a nucleic acid fragment/ 
complete expression unit as a label in immunoassays and 
demonstrates that the transcription/translation process can form 
the basis for a highly sensitive analytical system. 
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